# The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis

> **NCT01068444** · PHASE2 · COMPLETED · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 90 (actual)

## Conditions studied

- Hepatitis

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01068444
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2020-07
- **Final completion:** 2020-07
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01068444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01068444, "The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01068444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*